Insider Transactions in Q2 2021 at Pds Biotechnology Corp (PDSB)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2021
|
De Lyle W Bloomquist |
BUY
Open market or private purchase
|
Direct |
10,000
+4.9%
|
$90,000
$9.88 P/Share
|
|
Jun 16
2021
|
De Lyle W Bloomquist |
BUY
Exercise of conversion of derivative security
|
Direct |
2,970
+1.59%
|
$14,850
$5.99 P/Share
|
|
Jun 15
2021
|
Gregory Gene Freitag |
BUY
Open market or private purchase
|
Direct |
5,882
+11.3%
|
$47,056
$8.5 P/Share
|
|
Jun 15
2021
|
Seth Van Voorhees Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
17,647
+50.0%
|
$141,176
$8.5 P/Share
|
|
Jun 15
2021
|
Kamil Ali Jackson |
BUY
Open market or private purchase
|
Direct |
11,764
+50.0%
|
$94,112
$8.5 P/Share
|
|
Jun 15
2021
|
Steve C Glover |
BUY
Open market or private purchase
|
Direct |
5,882
+8.44%
|
$47,056
$8.5 P/Share
|
|
Jun 15
2021
|
Frank Bedu Addo President/CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,166
-4.03%
|
$325,992
$12.86 P/Share
|
|
Jun 15
2021
|
Frank Bedu Addo President/CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,174
+7.32%
|
$319,044
$6.57 P/Share
|